Cefoperazone sodium, sulbactam sodium.
Each 1 g vial contains cefoperazone sodium 500 mg and sulbactam sodium 500 mg.
Upper and lower respiratory tract infections, upper and lower urinary tract infections; peritonitis, cholecystitis, cholangitis, other intra-abdominal infections; skin and soft tissue infections.
Adults: 2-4 g daily in 2 divided doses. Maximum of 4 g/day. Children: 40-80 mg/kg/day in 2-4 divided doses. Maximum of 160 mg/kg/day.
Hypersensitivity to penicillin, sulbactam, cefoperazone or other cephalosporins.
Patients with poor diet, malabsorption or receiving parenteral nutrition for long-term period. Patients with liver and kidney disfunction.
Use in pregnancy and lactation: Cefratam injection is not recommended for pregnant and lactating women.
Diarrhea, nausea, vomiting, maculopapular rash, urticaria, eosinophilia, drug fever, reversible neutropenia, reduced hemoglobin or hematocrit. May cause false positive result on the direct Coombs' test; headache, fever, pain at injection site, trembling; increased SGOT/SGPT, alkaline phosphatase, bilirubin.
Alcohol, aminoglycosides, ringer lactate solution, lidocaine.
J01DD62 - cefoperazone and beta-lactamase inhibitor ; Belongs to the class of third-generation cephalosporins. Used in the systemic treatment of infections.